Literature DB >> 20483728

Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.

Daniel C Peltier1, Allison Simms, Jocelyn R Farmer, David J Miller.   

Abstract

Innate immune pathways are early defense responses important for the immediate control and eventual clearance of many pathogens, where signaling is initiated via pattern recognition receptor (PRR)-mediated events that occur in a ligand- and cell-type specific manner. Within CNS neurons, innate immune pathways are likely crucial to control pathogens that target these essential yet virtually irreplaceable cells. However, relatively little is known about the induction and regulation of neuronal PRR signaling. In this report, we used human neuronal cell lines and primary rat neuronal cultures to examine PRR expression and function. We found that several innate immune receptor ligands, including Sendai virus, the dsRNA mimetic polyinosinic-polycytidylic acid, and LPS all activated differentiation-dependent neuronal innate immune pathways. Functional genetic analyses revealed that IFN regulatory factor 3-mediated pathways that resulted in IFN-beta transcriptional upregulation were activated in cultured human neuronal cells by the PRRs TLR3, MDA5, or RIG-I in a ligand-specific manner. Furthermore, genome-wide transcriptional array and targeted genetic and pharmacologic analyses identified PI3K signaling as crucial for the induction of innate immune pathways in neurons. These results indicate that human neuronal cells possess specific and functional PRR pathways essential for the effective induction of innate immune responses, and suggest that neurons can play an active role in defense against neurotropic pathogens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483728      PMCID: PMC2887731          DOI: 10.4049/jimmunol.0904133

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

1.  Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Kanae Matsumoto; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Eileen Foy; Yueh-Ming Loo; Michael Gale; Shizuo Akira; Shin Yonehara; Atsushi Kato; Takashi Fujita
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Cell type-specific involvement of RIG-I in antiviral response.

Authors:  Hiroki Kato; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Satoshi Uematsu; Kosuke Matsui; Tohru Tsujimura; Kiyoshi Takeda; Takashi Fujita; Osamu Takeuchi; Shizuo Akira
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

3.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

4.  Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon.

Authors:  Christophe Préhaud; Françoise Mégret; Mireille Lafage; Monique Lafon
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  PI 3-kinase p110beta: a new target for antithrombotic therapy.

Authors:  Shaun P Jackson; Simone M Schoenwaelder; Isaac Goncalves; Warwick S Nesbitt; Cindy L Yap; Christine E Wright; Vijaya Kenche; Karen E Anderson; Sacha M Dopheide; Yuping Yuan; Sharelle A Sturgeon; Hishani Prabaharan; Philip E Thompson; Gregg D Smith; Peter R Shepherd; Nathalie Daniele; Suhasini Kulkarni; Belinda Abbott; Dilek Saylik; Catherine Jones; Lucy Lu; Simon Giuliano; Sascha C Hughan; James A Angus; Alan D Robertson; Hatem H Salem
Journal:  Nat Med       Date:  2005-04-17       Impact factor: 53.440

6.  Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Authors:  Kui Li; Zihong Chen; Nobuyuki Kato; Michael Gale; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

7.  Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.

Authors:  Ezra Aksoy; Wim Vanden Berghe; Sophie Detienne; Zoulikha Amraoui; Kathrine A Fitzgerald; Guy Haegeman; Michel Goldman; Fabienne Willems
Journal:  Eur J Immunol       Date:  2005-07       Impact factor: 5.532

8.  Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.

Authors:  Tian Wang; Terrence Town; Lena Alexopoulou; John F Anderson; Erol Fikrig; Richard A Flavell
Journal:  Nat Med       Date:  2004-11-21       Impact factor: 53.440

9.  Opposite effects of wortmannin and 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride on toll-like receptor-mediated nitric oxide production: negative regulation of nuclear factor-{kappa}B by phosphoinositide 3-kinase.

Authors:  Kaoru Hazeki; Sachiko Kinoshita; Takayo Matsumura; Kiyomi Nigorikawa; Hiroshi Kubo; Osamu Hazeki
Journal:  Mol Pharmacol       Date:  2006-02-10       Impact factor: 4.436

Review 10.  Signalling by PI3K isoforms: insights from gene-targeted mice.

Authors:  Bart Vanhaesebroeck; Khaled Ali; Antonio Bilancio; Barbara Geering; Lazaros C Foukas
Journal:  Trends Biochem Sci       Date:  2005-04       Impact factor: 13.807

View more
  39 in total

1.  Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling.

Authors:  Mallappa Anitha; Matam Vijay-Kumar; Shanthi V Sitaraman; Andrew T Gewirtz; Shanthi Srinivasan
Journal:  Gastroenterology       Date:  2012-06-23       Impact factor: 22.682

2.  Neurons are host cells for Mycobacterium tuberculosis.

Authors:  Philippa J Randall; Nai-Jen Hsu; Dirk Lang; Susan Cooper; Boipelo Sebesho; Nasiema Allie; Roanne Keeton; Ngiambudulu M Francisco; Sumayah Salie; Antoinette Labuschagné; Valerie Quesniaux; Bernhard Ryffel; Lauriston Kellaway; Muazzam Jacobs
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

3.  The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion.

Authors:  Didem Ağaç; Leonardo D Estrada; Robert Maples; Lora V Hooper; J David Farrar
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

Review 4.  Neuroinflammation During RNA Viral Infections.

Authors:  Robyn S Klein; Charise Garber; Kristen E Funk; Hamid Salimi; Allison Soung; Marlene Kanmogne; Sindhu Manivasagam; Shannon Agner; Matthew Cain
Journal:  Annu Rev Immunol       Date:  2019-04-26       Impact factor: 28.527

5.  Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia.

Authors:  Bolanle M Famakin; Yongshan Mou; Christl A Ruetzler; Joliet Bembry; Dragan Maric; John M Hallenbeck
Journal:  Brain Res       Date:  2011-03-01       Impact factor: 3.252

Review 6.  Understanding and altering cell tropism of vesicular stomatitis virus.

Authors:  Eric Hastie; Marcela Cataldi; Ian Marriott; Valery Z Grdzelishvili
Journal:  Virus Res       Date:  2013-06-22       Impact factor: 3.303

7.  Influence of perineurial cells and Toll-like receptors 2 and 9 on Herpes simplex type 1 entry to the central nervous system in rat encephalitis.

Authors:  Biborka Bereczky-Veress; Nada Abdelmagid; Fredrik Piehl; Tomas Bergström; Tomas Olsson; Birgit Sköldenberg; Margarita Diez
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

Review 8.  Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.

Authors:  Lidia Fernández-Paredes; Rebeca Pérez de Diego; Clara de Andrés; Silvia Sánchez-Ramón
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

9.  Neurons versus herpes simplex virus: the innate immune interactions that contribute to a host-pathogen standoff.

Authors:  Pamela C Rosato; David A Leib
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

10.  Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.

Authors:  Phillip C Delekta; Craig J Dobry; Janice A Sindac; Scott J Barraza; Pennelope K Blakely; Jianming Xiang; Paul D Kirchhoff; Richard F Keep; David N Irani; Scott D Larsen; David J Miller
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.